166 related articles for article (PubMed ID: 30887154)
1. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
Qin J; Wang S; Wang P; Wang X; Ye H; Song C; Dai L; Wang K; Jiang B; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1253-1262. PubMed ID: 30887154
[TBL] [Abstract][Full Text] [Related]
2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
3. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
5. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.
Lai H; Jin Q; Lin Y; Mo X; Li B; He K; Chen J
Tumour Biol; 2014 Oct; 35(10):10547-54. PubMed ID: 25060181
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
8. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.
Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604
[TBL] [Abstract][Full Text] [Related]
9. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
10. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.
Liu XX; Ye H; Wang P; Zhang Y; Zhang JY
Mol Med Rep; 2017 Nov; 16(5):7759-7765. PubMed ID: 28944820
[TBL] [Abstract][Full Text] [Related]
11. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
Li F; Guo Y; Liu J; Zhang R
PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
[TBL] [Abstract][Full Text] [Related]
12. Using Serological Proteome Analysis to Identify and Evaluate Anti-GRP78 Autoantibody as Biomarker in the Detection of Gastric Cancer.
Qin J; Yang Q; Ye H; Wang K; Zhang M; Zhu J; Wang X; Dai L; Wang P; Zhang J
J Oncol; 2020; 2020():9430737. PubMed ID: 33381181
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
14. Anti-FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer.
Kobayashi S; Hiwasa T; Ishige T; Kano M; Hoshino T; Rahmutulla B; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2021 Feb; 112(2):847-858. PubMed ID: 33306856
[TBL] [Abstract][Full Text] [Related]
15. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.
Chen XZ; Zhang WH; Chen HN; Liu JP; He D; Liu Y; Liu K; Chen XL; Mo XM; Zhou ZG; Hu JK
Oncotarget; 2016 Apr; 7(17):23647-57. PubMed ID: 27027339
[TBL] [Abstract][Full Text] [Related]
16. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
[TBL] [Abstract][Full Text] [Related]
17. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
18. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
